company background image
BWAY logo

BrainsWay TASE:BWAY Stock Report

Last Price

₪12.21

Market Cap

₪407.0m

7D

3.3%

1Y

175.6%

Updated

21 Jul, 2024

Data

Company Financials +

BWAY Stock Overview

Develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally.

BWAY fundamental analysis
Snowflake Score
Valuation4/6
Future Growth4/6
Past Performance0/6
Financial Health6/6
Dividends0/6

BrainsWay Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BrainsWay
Historical stock prices
Current Share Price₪12.21
52 Week High₪14.01
52 Week Low₪4.00
Beta0.33
11 Month Change6.54%
3 Month Change30.24%
1 Year Change175.62%
33 Year Change-17.89%
5 Year Change-32.09%
Change since IPO-20.84%

Recent News & Updates

We Think BrainsWay (TLV:BWAY) Can Easily Afford To Drive Business Growth

May 03
We Think BrainsWay (TLV:BWAY) Can Easily Afford To Drive Business Growth

Recent updates

We Think BrainsWay (TLV:BWAY) Can Easily Afford To Drive Business Growth

May 03
We Think BrainsWay (TLV:BWAY) Can Easily Afford To Drive Business Growth

BrainsWay Ltd.'s (TLV:BWAY) P/S Is Still On The Mark Following 26% Share Price Bounce

Dec 25
BrainsWay Ltd.'s (TLV:BWAY) P/S Is Still On The Mark Following 26% Share Price Bounce

We're Hopeful That BrainsWay (TLV:BWAY) Will Use Its Cash Wisely

Dec 21
We're Hopeful That BrainsWay (TLV:BWAY) Will Use Its Cash Wisely

We're Hopeful That BrainsWay (TLV:BWAY) Will Use Its Cash Wisely

Sep 19
We're Hopeful That BrainsWay (TLV:BWAY) Will Use Its Cash Wisely

We're Keeping An Eye On BrainsWay's (TLV:BWAY) Cash Burn Rate

Jun 01
We're Keeping An Eye On BrainsWay's (TLV:BWAY) Cash Burn Rate

We Think BrainsWay (TLV:BWAY) Can Afford To Drive Business Growth

Aug 15
We Think BrainsWay (TLV:BWAY) Can Afford To Drive Business Growth

BrainsWay (TLV:BWAY) Is In A Good Position To Deliver On Growth Plans

May 13
BrainsWay (TLV:BWAY) Is In A Good Position To Deliver On Growth Plans

BrainsWay (TLV:BWAY) Is In A Strong Position To Grow Its Business

Jan 31
BrainsWay (TLV:BWAY) Is In A Strong Position To Grow Its Business

What Is The Ownership Structure Like For Brainsway Ltd. (TLV:BWAY)?

Mar 02
What Is The Ownership Structure Like For Brainsway Ltd. (TLV:BWAY)?

What Type Of Returns Would Brainsway's(TLV:BWAY) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Jan 25
What Type Of Returns Would Brainsway's(TLV:BWAY) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?

Brainsway Ltd. (TLV:BWAY): Is Breakeven Near?

Dec 26
Brainsway Ltd. (TLV:BWAY): Is Breakeven Near?

Shareholder Returns

BWAYIL Medical EquipmentIL Market
7D3.3%5.6%0.6%
1Y175.6%13.2%-2.9%

Return vs Industry: BWAY exceeded the IL Medical Equipment industry which returned 13.2% over the past year.

Return vs Market: BWAY exceeded the IL Market which returned -2.9% over the past year.

Price Volatility

Is BWAY's price volatile compared to industry and market?
BWAY volatility
BWAY Average Weekly Movement5.9%
Medical Equipment Industry Average Movement6.4%
Market Average Movement4.4%
10% most volatile stocks in IL Market7.6%
10% least volatile stocks in IL Market3.1%

Stable Share Price: BWAY has not had significant price volatility in the past 3 months.

Volatility Over Time: BWAY's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of IL stocks.

About the Company

FoundedEmployeesCEOWebsite
2003134Hadar Levywww.brainsway.com

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer’s disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson’s diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry.

BrainsWay Ltd. Fundamentals Summary

How do BrainsWay's earnings and revenue compare to its market cap?
BWAY fundamental statistics
Market cap₪407.02m
Earnings (TTM)-₪6.03m
Revenue (TTM)₪124.86m

3.3x

P/S Ratio

-67.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BWAY income statement (TTM)
RevenueUS$34.26m
Cost of RevenueUS$8.80m
Gross ProfitUS$25.46m
Other ExpensesUS$27.11m
Earnings-US$1.65m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.05
Gross Margin74.31%
Net Profit Margin-4.83%
Debt/Equity Ratio0%

How did BWAY perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.